1h Free Analyst Time
The global amyotrophic lateral sclerosis treatment market is forecasted to grow by USD 200.4 million during 2025-2030, accelerating at a CAGR of 4.5% during the forecast period. The report on the global amyotrophic lateral sclerosis treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rise in precision medicine and genetically targeted therapies, favorable regulatory frameworks and accelerated clinical development pathways, expansion of specialized healthcare infrastructure and diagnostic capabilities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global amyotrophic lateral sclerosis treatment market is segmented as below:
By Route Of Administration
- Intravenous
- Oral
By Distribution Channel
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
By Drug Class
- Riluzole
- Symptomatic treatments
- Edaravone
- Muscle relaxants
- Antisense oligonucleotides
By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
The report on the global amyotrophic lateral sclerosis treatment market covers the following areas:
- Global amyotrophic lateral sclerosis treatment market sizing
- Global amyotrophic lateral sclerosis treatment market forecast
- Global amyotrophic lateral sclerosis treatment market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Amyotrophic Lateral Sclerosis Treatment Market 2020 - 2024
- Historic Market Size - Data Table on Global Amyotrophic Lateral Sclerosis Treatment Market 2020 - 2024 ($ million)
- Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
- Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
- Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on Global Amyotrophic Lateral Sclerosis Treatment Market
6.2 Impact of geopolitical conflicts on Global Amyotrophic Lateral Sclerosis Treatment Market
6.2 Impact of geopolitical conflicts on Global Amyotrophic Lateral Sclerosis Treatment Market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Route of Administration
8.1 Market segments
- Chart on Route of Administration - Market share 2025-2030 (%)
- Data Table on Route of Administration - Market share 2025-2030 (%)
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- Chart on Intravenous - Market size and forecast 2025-2030 ($ million)
- Data Table on Intravenous - Market size and forecast 2025-2030 ($ million)
- Chart on Intravenous - Year-over-year growth 2025-2030 (%)
- Data Table on Intravenous - Year-over-year growth 2025-2030 (%)
- Chart on Oral - Market size and forecast 2025-2030 ($ million)
- Data Table on Oral - Market size and forecast 2025-2030 ($ million)
- Chart on Oral - Year-over-year growth 2025-2030 (%)
- Data Table on Oral - Year-over-year growth 2025-2030 (%)
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
9 Market Segmentation by Distribution Channel
9.1 Market segments
- Chart on Distribution Channel - Market share 2025-2030 (%)
- Data Table on Distribution Channel - Market share 2025-2030 (%)
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- Chart on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
- Data Table on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
- Chart on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
- Data Table on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
- Chart on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
- Data Table on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
- Chart on Retail pharmacies - Year-over-year growth 2025-2030 (%)
- Data Table on Retail pharmacies - Year-over-year growth 2025-2030 (%)
- Chart on Online pharmacies - Market size and forecast 2025-2030 ($ million)
- Data Table on Online pharmacies - Market size and forecast 2025-2030 ($ million)
- Chart on Online pharmacies - Year-over-year growth 2025-2030 (%)
- Data Table on Online pharmacies - Year-over-year growth 2025-2030 (%)
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
10 Market Segmentation by Drug Class
10.1 Market segments
- Chart on Drug Class - Market share 2025-2030 (%)
- Data Table on Drug Class - Market share 2025-2030 (%)
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class
- Chart on Riluzole - Market size and forecast 2025-2030 ($ million)
- Data Table on Riluzole - Market size and forecast 2025-2030 ($ million)
- Chart on Riluzole - Year-over-year growth 2025-2030 (%)
- Data Table on Riluzole - Year-over-year growth 2025-2030 (%)
- Chart on Symptomatic treatments - Market size and forecast 2025-2030 ($ million)
- Data Table on Symptomatic treatments - Market size and forecast 2025-2030 ($ million)
- Chart on Symptomatic treatments - Year-over-year growth 2025-2030 (%)
- Data Table on Symptomatic treatments - Year-over-year growth 2025-2030 (%)
- Chart on Edaravone - Market size and forecast 2025-2030 ($ million)
- Data Table on Edaravone - Market size and forecast 2025-2030 ($ million)
- Chart on Edaravone - Year-over-year growth 2025-2030 (%)
- Data Table on Edaravone - Year-over-year growth 2025-2030 (%)
- Chart on Muscle relaxants - Market size and forecast 2025-2030 ($ million)
- Data Table on Muscle relaxants - Market size and forecast 2025-2030 ($ million)
- Chart on Muscle relaxants - Year-over-year growth 2025-2030 (%)
- Data Table on Muscle relaxants - Year-over-year growth 2025-2030 (%)
- Chart on Antisense oligonucleotides - Market size and forecast 2025-2030 ($ million)
- Data Table on Antisense oligonucleotides - Market size and forecast 2025-2030 ($ million)
- Chart on Antisense oligonucleotides - Year-over-year growth 2025-2030 (%)
- Data Table on Antisense oligonucleotides - Year-over-year growth 2025-2030 (%)
- Market opportunity by Drug Class ($ million)
- Data Table on Market opportunity by Drug Class ($ million)
11 Customer Landscape
11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ million)
- Data Table on Canada - Market size and forecast 2025-2030 ($ million)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ million)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2025-2030 ($ million)
- Data Table on Germany - Market size and forecast 2025-2030 ($ million)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on UK - Market size and forecast 2025-2030 ($ million)
- Data Table on UK - Market size and forecast 2025-2030 ($ million)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ million)
- Data Table on France - Market size and forecast 2025-2030 ($ million)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ million)
- Data Table on Italy - Market size and forecast 2025-2030 ($ million)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ million)
- Data Table on Spain - Market size and forecast 2025-2030 ($ million)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on Japan - Market size and forecast 2025-2030 ($ million)
- Data Table on Japan - Market size and forecast 2025-2030 ($ million)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on China - Market size and forecast 2025-2030 ($ million)
- Data Table on China - Market size and forecast 2025-2030 ($ million)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ million)
- Data Table on India - Market size and forecast 2025-2030 ($ million)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ million)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Singapore - Market size and forecast 2025-2030 ($ million)
- Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
- Chart on Singapore - Year-over-year growth 2025-2030 (%)
- Data Table on Singapore - Year-over-year growth 2025-2030 (%)
- Chart on Thailand - Market size and forecast 2025-2030 ($ million)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Australia - Market size and forecast 2025-2030 ($ million)
- Data Table on Australia - Market size and forecast 2025-2030 ($ million)
- Chart on Australia - Year-over-year growth 2025-2030 (%)
- Data Table on Australia - Year-over-year growth 2025-2030 (%)
- Chart on Brazil - Market size and forecast 2025-2030 ($ million)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on Argentina - Market size and forecast 2025-2030 ($ million)
- Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
- Chart on Argentina - Year-over-year growth 2025-2030 (%)
- Data Table on Argentina - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ million)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ million)
- Data Table on UAE - Market size and forecast 2025-2030 ($ million)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on Chile - Market size and forecast 2025-2030 ($ million)
- Data Table on Chile - Market size and forecast 2025-2030 ($ million)
- Chart on Chile - Year-over-year growth 2025-2030 (%)
- Data Table on Chile - Year-over-year growth 2025-2030 (%)
- Chart on New Zealand - Market size and forecast 2025-2030 ($ million)
- Data Table on New Zealand - Market size and forecast 2025-2030 ($ million)
- Chart on New Zealand - Year-over-year growth 2025-2030 (%)
- Data Table on New Zealand - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
- Rise in precision medicine and genetically targeted therapies
- Favorable regulatory frameworks and accelerated clinical development pathways
- Expansion of specialized healthcare infrastructure and diagnostic capabilities
- High attrition rates and late-stage clinical trial failures
- Prohibitive treatment costs and complex reimbursement obstacles
- Specialized manufacturing and supply chain complexities
- Impact of drivers and challenges in 2025 and 2030
- Integration of AI and digital biomarkers in clinical research
- Shift toward combination therapies and multi-targeted mechanistic approaches
- Decentralized clinical trials and enhanced patient-centric frameworks
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- AB Science SA - Overview
- AB Science SA - Product / Service
- AB Science SA - Key offerings
- SWOT
- Alkem Laboratories Ltd. - Overview
- Alkem Laboratories Ltd. - Business segments
- Alkem Laboratories Ltd. - Key offerings
- Alkem Laboratories Ltd. - Segment focus
- SWOT
- Apotex Inc. - Overview
- Apotex Inc. - Product / Service
- Apotex Inc. - Key offerings
- SWOT
- Aquestive Therapeutics Inc - Overview
- Aquestive Therapeutics Inc - Product / Service
- Aquestive Therapeutics Inc - Key offerings
- SWOT
- Biogen Inc. - Overview
- Biogen Inc. - Product / Service
- Biogen Inc. - Key news
- Biogen Inc. - Key offerings
- SWOT
- CorestemChemon Inc. - Overview
- CorestemChemon Inc. - Product / Service
- CorestemChemon Inc. - Key offerings
- SWOT
- Cytokinetics Inc. - Overview
- Cytokinetics Inc. - Product / Service
- Cytokinetics Inc. - Key offerings
- SWOT
- Dr. Reddys Laboratories Ltd. - Overview
- Dr. Reddys Laboratories Ltd. - Business segments
- Dr. Reddys Laboratories Ltd. - Key news
- Dr. Reddys Laboratories Ltd. - Key offerings
- Dr. Reddys Laboratories Ltd. - Segment focus
- SWOT
- Ionis Pharmaceuticals Inc. - Overview
- Ionis Pharmaceuticals Inc. - Product / Service
- Ionis Pharmaceuticals Inc. - Key news
- Ionis Pharmaceuticals Inc. - Key offerings
- SWOT
- Italfarmaco Holding SPA - Overview
- Italfarmaco Holding SPA - Product / Service
- Italfarmaco Holding SPA - Key offerings
- SWOT
- Otsuka Holdings Co. Ltd. - Overview
- Otsuka Holdings Co. Ltd. - Business segments
- Otsuka Holdings Co. Ltd. - Key offerings
- Otsuka Holdings Co. Ltd. - Segment focus
- SWOT
- Revalesio Corp. - Overview
- Revalesio Corp. - Product / Service
- Revalesio Corp. - Key offerings
- SWOT
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
- Sun Pharmaceutical Industries - Overview
- Sun Pharmaceutical Industries - Business segments
- Sun Pharmaceutical Industries - Key news
- Sun Pharmaceutical Industries - Key offerings
- Sun Pharmaceutical Industries - Segment focus
- SWOT
- The Mitsubishi Chemical Group - Overview
- The Mitsubishi Chemical Group - Business segments
- The Mitsubishi Chemical Group - Key news
- The Mitsubishi Chemical Group - Key offerings
- The Mitsubishi Chemical Group - Segment focus
- SWOT
16 Appendix
16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 7: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Amyotrophic Lateral Sclerosis Treatment Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 39: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Route of Administration
Exhibit 41: Data Table on Comparison by Route of Administration
Exhibit 42: Chart on Intravenous - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Intravenous - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Intravenous - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Intravenous - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 50: Market opportunity by Route of Administration ($ million)
Exhibit 51: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 52: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 53: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 54: Chart on Comparison by Distribution Channel
Exhibit 55: Data Table on Comparison by Distribution Channel
Exhibit 56: Chart on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 57: Data Table on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 58: Chart on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 59: Data Table on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 60: Chart on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 64: Chart on Online pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Data Table on Online pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 66: Chart on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 68: Market opportunity by Distribution Channel ($ million)
Exhibit 69: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 70: Chart on Drug Class - Market share 2025-2030 (%)
Exhibit 71: Data Table on Drug Class - Market share 2025-2030 (%)
Exhibit 72: Chart on Comparison by Drug Class
Exhibit 73: Data Table on Comparison by Drug Class
Exhibit 74: Chart on Riluzole - Market size and forecast 2025-2030 ($ million)
Exhibit 75: Data Table on Riluzole - Market size and forecast 2025-2030 ($ million)
Exhibit 76: Chart on Riluzole - Year-over-year growth 2025-2030 (%)
Exhibit 77: Data Table on Riluzole - Year-over-year growth 2025-2030 (%)
Exhibit 78: Chart on Symptomatic treatments - Market size and forecast 2025-2030 ($ million)
Exhibit 79: Data Table on Symptomatic treatments - Market size and forecast 2025-2030 ($ million)
Exhibit 80: Chart on Symptomatic treatments - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Symptomatic treatments - Year-over-year growth 2025-2030 (%)
Exhibit 82: Chart on Edaravone - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on Edaravone - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on Edaravone - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Edaravone - Year-over-year growth 2025-2030 (%)
Exhibit 86: Chart on Muscle relaxants - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Data Table on Muscle relaxants - Market size and forecast 2025-2030 ($ million)
Exhibit 88: Chart on Muscle relaxants - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on Muscle relaxants - Year-over-year growth 2025-2030 (%)
Exhibit 90: Chart on Antisense oligonucleotides - Market size and forecast 2025-2030 ($ million)
Exhibit 91: Data Table on Antisense oligonucleotides - Market size and forecast 2025-2030 ($ million)
Exhibit 92: Chart on Antisense oligonucleotides - Year-over-year growth 2025-2030 (%)
Exhibit 93: Data Table on Antisense oligonucleotides - Year-over-year growth 2025-2030 (%)
Exhibit 94: Market opportunity by Drug Class ($ million)
Exhibit 95: Data Table on Market opportunity by Drug Class ($ million)
Exhibit 96: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 97: Chart on Market share by geography 2025-2030 (%)
Exhibit 98: Data Table on Market share by geography 2025-2030 (%)
Exhibit 99: Chart on Geographic comparison
Exhibit 100: Data Table on Geographic comparison
Exhibit 101: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 102: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 103: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 104: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 105: Chart on Regional Comparison - North America
Exhibit 106: Data Table on Regional Comparison - North America
Exhibit 107: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 108: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 109: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 110: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 111: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 121: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Regional Comparison - Europe
Exhibit 124: Data Table on Regional Comparison - Europe
Exhibit 125: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 126: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on Regional Comparison - Asia
Exhibit 154: Data Table on Regional Comparison - Asia
Exhibit 155: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 184: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 185: Chart on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on Chile - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on Chile - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on Chile - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on Chile - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on New Zealand - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on New Zealand - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on New Zealand - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on New Zealand - Year-over-year growth 2025-2030 (%)
Exhibit 217: Market opportunity by geography ($ million)
Exhibit 218: Data Tables on Market opportunity by geography ($ million)
Exhibit 219: Impact of drivers and challenges in 2025 and 2030
Exhibit 220: Overview on criticality of inputs and factors of differentiation
Exhibit 221: Overview on factors of disruption
Exhibit 222: Impact of key risks on business
Exhibit 223: Companies covered
Exhibit 224: Company ranking index
Exhibit 225: Matrix on companies position and classification
Exhibit 226: AB Science SA - Overview
Exhibit 227: AB Science SA - Product / Service
Exhibit 228: AB Science SA - Key offerings
Exhibit 229: SWOT
Exhibit 230: Alkem Laboratories Ltd. - Overview
Exhibit 231: Alkem Laboratories Ltd. - Business segments
Exhibit 232: Alkem Laboratories Ltd. - Key offerings
Exhibit 233: Alkem Laboratories Ltd. - Segment focus
Exhibit 234: SWOT
Exhibit 235: Apotex Inc. - Overview
Exhibit 236: Apotex Inc. - Product / Service
Exhibit 237: Apotex Inc. - Key offerings
Exhibit 238: SWOT
Exhibit 239: Aquestive Therapeutics Inc - Overview
Exhibit 240: Aquestive Therapeutics Inc - Product / Service
Exhibit 241: Aquestive Therapeutics Inc - Key offerings
Exhibit 242: SWOT
Exhibit 243: Biogen Inc. - Overview
Exhibit 244: Biogen Inc. - Product / Service
Exhibit 245: Biogen Inc. - Key news
Exhibit 246: Biogen Inc. - Key offerings
Exhibit 247: SWOT
Exhibit 248: CorestemChemon Inc. - Overview
Exhibit 249: CorestemChemon Inc. - Product / Service
Exhibit 250: CorestemChemon Inc. - Key offerings
Exhibit 251: SWOT
Exhibit 252: Cytokinetics Inc. - Overview
Exhibit 253: Cytokinetics Inc. - Product / Service
Exhibit 254: Cytokinetics Inc. - Key offerings
Exhibit 255: SWOT
Exhibit 256: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 257: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 258: Dr. Reddys Laboratories Ltd. - Key news
Exhibit 259: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 260: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibit 261: SWOT
Exhibit 262: Ionis Pharmaceuticals Inc. - Overview
Exhibit 263: Ionis Pharmaceuticals Inc. - Product / Service
Exhibit 264: Ionis Pharmaceuticals Inc. - Key news
Exhibit 265: Ionis Pharmaceuticals Inc. - Key offerings
Exhibit 266: SWOT
Exhibit 267: Italfarmaco Holding SPA - Overview
Exhibit 268: Italfarmaco Holding SPA - Product / Service
Exhibit 269: Italfarmaco Holding SPA - Key offerings
Exhibit 270: SWOT
Exhibit 271: Otsuka Holdings Co. Ltd. - Overview
Exhibit 272: Otsuka Holdings Co. Ltd. - Business segments
Exhibit 273: Otsuka Holdings Co. Ltd. - Key offerings
Exhibit 274: Otsuka Holdings Co. Ltd. - Segment focus
Exhibit 275: SWOT
Exhibit 276: Revalesio Corp. - Overview
Exhibit 277: Revalesio Corp. - Product / Service
Exhibit 278: Revalesio Corp. - Key offerings
Exhibit 279: SWOT
Exhibit 280: Sanofi SA - Overview
Exhibit 281: Sanofi SA - Business segments
Exhibit 282: Sanofi SA - Key news
Exhibit 283: Sanofi SA - Key offerings
Exhibit 284: Sanofi SA - Segment focus
Exhibit 285: SWOT
Exhibit 286: Sun Pharmaceutical Industries - Overview
Exhibit 287: Sun Pharmaceutical Industries - Business segments
Exhibit 288: Sun Pharmaceutical Industries - Key news
Exhibit 289: Sun Pharmaceutical Industries - Key offerings
Exhibit 290: Sun Pharmaceutical Industries - Segment focus
Exhibit 291: SWOT
Exhibit 292: The Mitsubishi Chemical Group - Overview
Exhibit 293: The Mitsubishi Chemical Group - Business segments
Exhibit 294: The Mitsubishi Chemical Group - Key news
Exhibit 295: The Mitsubishi Chemical Group - Key offerings
Exhibit 296: The Mitsubishi Chemical Group - Segment focus
Exhibit 297: SWOT
Exhibit 298: Inclusions checklist
Exhibit 299: Exclusions checklist
Exhibit 300: Currency conversion rates for US$
Exhibit 301: Research methodology
Exhibit 302: Information sources
Exhibit 303: Data validation
Exhibit 304: Validation techniques employed for market sizing
Exhibit 305: Data synthesis
Exhibit 306: 360 degree market analysis
Exhibit 307: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 7: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Amyotrophic Lateral Sclerosis Treatment Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 39: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Route of Administration
Exhibit 41: Data Table on Comparison by Route of Administration
Exhibit 42: Chart on Intravenous - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Intravenous - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Intravenous - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Intravenous - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 50: Market opportunity by Route of Administration ($ million)
Exhibit 51: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 52: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 53: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 54: Chart on Comparison by Distribution Channel
Exhibit 55: Data Table on Comparison by Distribution Channel
Exhibit 56: Chart on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 57: Data Table on Hospital pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 58: Chart on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 59: Data Table on Hospital pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 60: Chart on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Retail pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Retail pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 64: Chart on Online pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Data Table on Online pharmacies - Market size and forecast 2025-2030 ($ million)
Exhibit 66: Chart on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on Online pharmacies - Year-over-year growth 2025-2030 (%)
Exhibit 68: Market opportunity by Distribution Channel ($ million)
Exhibit 69: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 70: Chart on Drug Class - Market share 2025-2030 (%)
Exhibit 71: Data Table on Drug Class - Market share 2025-2030 (%)
Exhibit 72: Chart on Comparison by Drug Class
Exhibit 73: Data Table on Comparison by Drug Class
Exhibit 74: Chart on Riluzole - Market size and forecast 2025-2030 ($ million)
Exhibit 75: Data Table on Riluzole - Market size and forecast 2025-2030 ($ million)
Exhibit 76: Chart on Riluzole - Year-over-year growth 2025-2030 (%)
Exhibit 77: Data Table on Riluzole - Year-over-year growth 2025-2030 (%)
Exhibit 78: Chart on Symptomatic treatments - Market size and forecast 2025-2030 ($ million)
Exhibit 79: Data Table on Symptomatic treatments - Market size and forecast 2025-2030 ($ million)
Exhibit 80: Chart on Symptomatic treatments - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Symptomatic treatments - Year-over-year growth 2025-2030 (%)
Exhibit 82: Chart on Edaravone - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on Edaravone - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on Edaravone - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Edaravone - Year-over-year growth 2025-2030 (%)
Exhibit 86: Chart on Muscle relaxants - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Data Table on Muscle relaxants - Market size and forecast 2025-2030 ($ million)
Exhibit 88: Chart on Muscle relaxants - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on Muscle relaxants - Year-over-year growth 2025-2030 (%)
Exhibit 90: Chart on Antisense oligonucleotides - Market size and forecast 2025-2030 ($ million)
Exhibit 91: Data Table on Antisense oligonucleotides - Market size and forecast 2025-2030 ($ million)
Exhibit 92: Chart on Antisense oligonucleotides - Year-over-year growth 2025-2030 (%)
Exhibit 93: Data Table on Antisense oligonucleotides - Year-over-year growth 2025-2030 (%)
Exhibit 94: Market opportunity by Drug Class ($ million)
Exhibit 95: Data Table on Market opportunity by Drug Class ($ million)
Exhibit 96: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 97: Chart on Market share by geography 2025-2030 (%)
Exhibit 98: Data Table on Market share by geography 2025-2030 (%)
Exhibit 99: Chart on Geographic comparison
Exhibit 100: Data Table on Geographic comparison
Exhibit 101: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 102: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 103: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 104: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 105: Chart on Regional Comparison - North America
Exhibit 106: Data Table on Regional Comparison - North America
Exhibit 107: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 108: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 109: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 110: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 111: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 121: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Regional Comparison - Europe
Exhibit 124: Data Table on Regional Comparison - Europe
Exhibit 125: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 126: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on Regional Comparison - Asia
Exhibit 154: Data Table on Regional Comparison - Asia
Exhibit 155: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 184: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 185: Chart on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on Chile - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on Chile - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on Chile - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on Chile - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on New Zealand - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on New Zealand - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on New Zealand - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on New Zealand - Year-over-year growth 2025-2030 (%)
Exhibit 217: Market opportunity by geography ($ million)
Exhibit 218: Data Tables on Market opportunity by geography ($ million)
Exhibit 219: Impact of drivers and challenges in 2025 and 2030
Exhibit 220: Overview on criticality of inputs and factors of differentiation
Exhibit 221: Overview on factors of disruption
Exhibit 222: Impact of key risks on business
Exhibit 223: Companies covered
Exhibit 224: Company ranking index
Exhibit 225: Matrix on companies position and classification
Exhibit 226: AB Science SA - Overview
Exhibit 227: AB Science SA - Product / Service
Exhibit 228: AB Science SA - Key offerings
Exhibit 229: SWOT
Exhibit 230: Alkem Laboratories Ltd. - Overview
Exhibit 231: Alkem Laboratories Ltd. - Business segments
Exhibit 232: Alkem Laboratories Ltd. - Key offerings
Exhibit 233: Alkem Laboratories Ltd. - Segment focus
Exhibit 234: SWOT
Exhibit 235: Apotex Inc. - Overview
Exhibit 236: Apotex Inc. - Product / Service
Exhibit 237: Apotex Inc. - Key offerings
Exhibit 238: SWOT
Exhibit 239: Aquestive Therapeutics Inc - Overview
Exhibit 240: Aquestive Therapeutics Inc - Product / Service
Exhibit 241: Aquestive Therapeutics Inc - Key offerings
Exhibit 242: SWOT
Exhibit 243: Biogen Inc. - Overview
Exhibit 244: Biogen Inc. - Product / Service
Exhibit 245: Biogen Inc. - Key news
Exhibit 246: Biogen Inc. - Key offerings
Exhibit 247: SWOT
Exhibit 248: CorestemChemon Inc. - Overview
Exhibit 249: CorestemChemon Inc. - Product / Service
Exhibit 250: CorestemChemon Inc. - Key offerings
Exhibit 251: SWOT
Exhibit 252: Cytokinetics Inc. - Overview
Exhibit 253: Cytokinetics Inc. - Product / Service
Exhibit 254: Cytokinetics Inc. - Key offerings
Exhibit 255: SWOT
Exhibit 256: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 257: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 258: Dr. Reddys Laboratories Ltd. - Key news
Exhibit 259: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 260: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibit 261: SWOT
Exhibit 262: Ionis Pharmaceuticals Inc. - Overview
Exhibit 263: Ionis Pharmaceuticals Inc. - Product / Service
Exhibit 264: Ionis Pharmaceuticals Inc. - Key news
Exhibit 265: Ionis Pharmaceuticals Inc. - Key offerings
Exhibit 266: SWOT
Exhibit 267: Italfarmaco Holding SPA - Overview
Exhibit 268: Italfarmaco Holding SPA - Product / Service
Exhibit 269: Italfarmaco Holding SPA - Key offerings
Exhibit 270: SWOT
Exhibit 271: Otsuka Holdings Co. Ltd. - Overview
Exhibit 272: Otsuka Holdings Co. Ltd. - Business segments
Exhibit 273: Otsuka Holdings Co. Ltd. - Key offerings
Exhibit 274: Otsuka Holdings Co. Ltd. - Segment focus
Exhibit 275: SWOT
Exhibit 276: Revalesio Corp. - Overview
Exhibit 277: Revalesio Corp. - Product / Service
Exhibit 278: Revalesio Corp. - Key offerings
Exhibit 279: SWOT
Exhibit 280: Sanofi SA - Overview
Exhibit 281: Sanofi SA - Business segments
Exhibit 282: Sanofi SA - Key news
Exhibit 283: Sanofi SA - Key offerings
Exhibit 284: Sanofi SA - Segment focus
Exhibit 285: SWOT
Exhibit 286: Sun Pharmaceutical Industries - Overview
Exhibit 287: Sun Pharmaceutical Industries - Business segments
Exhibit 288: Sun Pharmaceutical Industries - Key news
Exhibit 289: Sun Pharmaceutical Industries - Key offerings
Exhibit 290: Sun Pharmaceutical Industries - Segment focus
Exhibit 291: SWOT
Exhibit 292: The Mitsubishi Chemical Group - Overview
Exhibit 293: The Mitsubishi Chemical Group - Business segments
Exhibit 294: The Mitsubishi Chemical Group - Key news
Exhibit 295: The Mitsubishi Chemical Group - Key offerings
Exhibit 296: The Mitsubishi Chemical Group - Segment focus
Exhibit 297: SWOT
Exhibit 298: Inclusions checklist
Exhibit 299: Exclusions checklist
Exhibit 300: Currency conversion rates for US$
Exhibit 301: Research methodology
Exhibit 302: Information sources
Exhibit 303: Data validation
Exhibit 304: Validation techniques employed for market sizing
Exhibit 305: Data synthesis
Exhibit 306: 360 degree market analysis
Exhibit 307: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global global amyotrophic lateral sclerosis treatment market: AB Science SA, Alkem Laboratories Ltd., Apotex Inc., Aquestive Therapeutics Inc, Biogen Inc., CorestemChemon Inc., Cytokinetics Inc., Dr. Reddys Laboratories Ltd., Ionis Pharmaceuticals Inc., Italfarmaco Holding SPA, Otsuka Holdings Co. Ltd., Revalesio Corp., Sanofi SA, Sun Pharmaceutical Industries, The Mitsubishi Chemical Group, Treeway BV.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is integration of ai and digital biomarkers in clinical research."
According to the report, one of the major drivers for this market is the rise in precision medicine and genetically targeted therapies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AB Science SA
- Alkem Laboratories Ltd.
- Apotex Inc.
- Aquestive Therapeutics Inc
- Biogen Inc.
- CorestemChemon Inc.
- Cytokinetics Inc.
- Dr. Reddys Laboratories Ltd.
- Ionis Pharmaceuticals Inc.
- Italfarmaco Holding SPA
- Otsuka Holdings Co. Ltd.
- Revalesio Corp.
- Sanofi SA
- Sun Pharmaceutical Industries
- The Mitsubishi Chemical Group
- Treeway BV
